Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Nederlands Tijdschrift Voor Geneeskunde
|
March 15, 2021
[Lymphadenopathy in general practice]
Jarom Heijmans, Sarah Krausz, Judy M van Es, et al.
Journal of Neuroimmunology
|
June 13, 2012
Sustained Rap1 activation in autoantigen-specific T lymphocytes attenuates experimental autoimmune encephalomyelitis
Gabriela Franco Salinas, Sarah Krausz, Wendy Dontje, et al.
Arthritis and Rheumatism
|
April 1, 2009
Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis
Bernard Vandooren, Troy Noordenbos, Carmen Ambarus, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 16, 2009
The presumed hyporesponsive behavior of rheumatoid arthritis T lymphocytes can be attributed to spontaneous ex vivo apoptosis rather than defects in T cell receptor signaling
Joana R F Abreu, Aleksander M Grabiec, Sarah Krausz, et al.
Arthritis and Rheumatism
|
July 28, 2010
Sustained T cell Rap1 signaling is protective in the collagen-induced arthritis model of rheumatoid arthritis
Joana R F Abreu, Sarah Krausz, Wendy Dontje, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 27, 2010
Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue
Aleksander M Grabiec, Sarah Krausz, Wilco de Jager, et al.
Plos One
|
January 10, 2014
Tie2 signaling cooperates with TNF to promote the pro-inflammatory activation of human macrophages independently of macrophage functional phenotype
Samuel García, Sarah Krausz, Carmen A Ambarus, et al.
Arthritis and Rheumatism
|
December 16, 2011
Brief report: a phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthritis
Sarah Krausz, Maria J H Boumans, Danielle M Gerlag, et al.
Annals of the Rheumatic Diseases
|
June 26, 2012
Angiopoietin-2 promotes inflammatory activation of human macrophages and is essential for murine experimental arthritis
Sarah Krausz, Samuel Garcia, Carmen A Ambarus, et al.
British Journal of Cancer
|
May 28, 2019
Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations
Annelieke E C A B Willemsen, Sarah Krausz, Marjolijn J L Ligtenberg, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Nederlands Tijdschrift Voor Geneeskunde
|
March 15, 2021
[Lymphadenopathy in general practice]
Jarom Heijmans, Sarah Krausz, Judy M van Es, et al.
Journal of Neuroimmunology
|
June 13, 2012
Sustained Rap1 activation in autoantigen-specific T lymphocytes attenuates experimental autoimmune encephalomyelitis
Gabriela Franco Salinas, Sarah Krausz, Wendy Dontje, et al.
Arthritis and Rheumatism
|
April 1, 2009
Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis
Bernard Vandooren, Troy Noordenbos, Carmen Ambarus, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 16, 2009
The presumed hyporesponsive behavior of rheumatoid arthritis T lymphocytes can be attributed to spontaneous ex vivo apoptosis rather than defects in T cell receptor signaling
Joana R F Abreu, Aleksander M Grabiec, Sarah Krausz, et al.
Arthritis and Rheumatism
|
July 28, 2010
Sustained T cell Rap1 signaling is protective in the collagen-induced arthritis model of rheumatoid arthritis
Joana R F Abreu, Sarah Krausz, Wendy Dontje, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 27, 2010
Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue
Aleksander M Grabiec, Sarah Krausz, Wilco de Jager, et al.
Plos One
|
January 10, 2014
Tie2 signaling cooperates with TNF to promote the pro-inflammatory activation of human macrophages independently of macrophage functional phenotype
Samuel García, Sarah Krausz, Carmen A Ambarus, et al.
Arthritis and Rheumatism
|
December 16, 2011
Brief report: a phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthritis
Sarah Krausz, Maria J H Boumans, Danielle M Gerlag, et al.
Annals of the Rheumatic Diseases
|
June 26, 2012
Angiopoietin-2 promotes inflammatory activation of human macrophages and is essential for murine experimental arthritis
Sarah Krausz, Samuel Garcia, Carmen A Ambarus, et al.
British Journal of Cancer
|
May 28, 2019
Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations
Annelieke E C A B Willemsen, Sarah Krausz, Marjolijn J L Ligtenberg, et al.
Page
of 2